Clinical trials: Parasitologically Confirmed; Malarial
Parasitologically Confirmed; Malarial
Artemether-Lumefantrine Clinical Effectiveness Study
In 2009, Papua New Guinea officially adopted artemether-lumefantrine (AL) as new national first-line drug for uncomplicated malaria.
- Trial name
- NCT01599000
- Testing
- Artemether-lumefantrine combination
- Where
- Papua New Guinea
- Volunteers
- 159 people
- Sponsor
- Papua New Guinea Institute of Medical Research